Fund Evaluation Group, LLC Novartis Ag Transaction History

Fund Evaluation Group, LLC

  • $1.81 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 12, 2019
SELL
$73.66 - $82.02 $1.01 Million - $1.12 Million
-13,653 Closed
0 $0
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $100,209 - $115,912
-1,497 Reduced 9.88%
13,653 $1.18 Million
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $1.1 Million - $1.18 Million
15,150
15,150 $1.27 Million

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Fund Evaluation Group, LLC Portfolio

Follow Fund Evaluation Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fund Evaluation Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fund Evaluation Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email